Press Releases

National Brain Tumor Society Statement on 2023 State of the Union Address National Brain Tumor Society (NBTS), the nation’s largest nonprofit dedicated to defeating brain tumors and improving the lives of patients with brain tumors, commends President Joe Biden for continuing to put cancer patients and cancer research at the forefront of the national public policy discussion.  During his 2023 State of the Union address, the president […] February 8, 2023

NBTS and IQVIA Announce Collaboration to Support DNA Damage Repair Research and Treatment Development in Brain Tumors National Brain Tumor Society (NBTS), the nation’s largest nonprofit dedicated to defeating brain tumors and improving the quality of brain tumor patients’ lives, and IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services, have announced a collaboration through IQVIA Biotech to support the development of DNA Damage Repair inhibitors for […] November 15, 2022

Brain Tumor Patient Advocacy Organizations Team Up to Advance Novel Imaging Framework to Evaluate Drug Efficacy Grant to UCLA researchers will validate an imaging-based clinical trial endpoint to better enable decision-making in brain tumor drug development  Today, the National Brain Tumor Society (NBTS), the nation’s largest nonprofit dedicated to defeating brain tumors and improving the lives of patients with brain tumors, and The Sontag Foundation, one of the largest private funders […] October 6, 2022

National Brain Tumor Society Marks the Signing of the Honoring Our PACT Act Today, National Brain Tumor Society (NBTS) Chief Executive Officer, David Arons, attended the White House ceremony for the signing of the Honoring Our PACT Act by President Joe Biden. Ahead of the signing, Mr. Arons released the following statement on behalf of NBTS: “National Brain Tumor Society supports enactment of the PACT Act and applauds […] August 10, 2022

National Brain Tumor Society Grant Seeks to Establish New Pipeline of Promising Meningioma Treatments Two highly experienced teams will work together to advance new drugs for the most common type of brain tumor Today, the National Brain Tumor Society (NBTS) announced a $400,000 grant to Drs. Priscilla K. Brastianos, Director, Central Nervous System Metastasis Center, Mass General Cancer Center (MGH), and Associate Professor of Medicine at Harvard Medical School, and Rachael […] May 30, 2022